(MC) Moelis - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US60786M1053
M&A, Restructuring, Capital, Advisory
Dividends
| Dividend Yield | 3.79% |
| Yield on Cost 5y | 8.20% |
| Yield CAGR 5y | -9.90% |
| Payout Consistency | 88.2% |
| Payout Ratio | 85.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 35.5% |
| Value at Risk 5%th | 56.9% |
| Relative Tail Risk | -2.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.08 |
| Alpha | -25.13 |
| CAGR/Max DD | 0.61 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.512 |
| Beta | 1.462 |
| Beta Downside | 1.537 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.31% |
| Mean DD | 10.98% |
| Median DD | 8.52% |
Description: MC Moelis November 06, 2025
Moelis & Company (NYSE: MC) is a global independent investment-banking advisory firm that provides M&A, recapitalization, restructuring, capital-markets, and private-funds advice to a broad client base that includes public multinationals, middle-market private firms, financial sponsors, entrepreneurs, governments, and sovereign wealth funds. Founded in 2007 and headquartered in New York, the firm operates across the Americas, Europe, the Middle East, Asia, and Australia.
In FY 2023 the firm generated roughly $1.5 billion in revenue, with a net income margin near 30 %-a level that ranks among the highest in the boutique investment-banking sector. Deal flow is highly sensitive to macro-driven M&A activity; the 2024 first-quarter U.S. M&A volume rose 12 % year-over-year, supporting higher advisory fees. Additionally, Moelis benefits from a low-fixed-cost model that allows it to scale earnings quickly when deal pipelines expand, a key advantage in a rising-interest-rate environment that pressures larger, capital-intensive banks.
For a deeper quantitative view of Moelis’s valuation dynamics and how its performance compares to peers, you may find ValueRay’s analytics platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (234.6m TTM) > 0 and > 6% of Revenue (6% = 88.1m TTM) |
| FCFTA 0.34 (>2.0%) and ΔFCFTA 17.46pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 22.73% (prev -32.19%; Δ 54.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.36 (>3.0%) and CFO 552.9m > Net Income 234.6m (YES >=105%, WARN >=100%) |
| Net Debt (-281.6m) to EBITDA (288.8m) ratio: -0.98 <= 3.0 (WARN <= 3.5) |
| Current Ratio 103.8 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (79.0m) change vs 12m ago 2.77% (target <= -2.0% for YES) |
| Gross Margin 32.89% (prev 22.58%; Δ 10.30pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 109.9% (prev 84.18%; Δ 25.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -5.58 (EBITDA TTM 288.8m / Interest Expense TTM -49.7m) >= 6 (WARN >= 3) |
Altman Z'' 0.06
| (A) 0.22 = (Total Current Assets 336.8m - Total Current Liabilities 3.24m) / Total Assets 1.52b |
| (B) -0.55 = Retained Earnings (Balance) -836.7m / Total Assets 1.52b |
| (C) 0.21 = EBIT TTM 277.4m / Avg Total Assets 1.34b |
| (D) -0.94 = Book Value of Equity -841.5m / Total Liabilities 898.6m |
| Total Rating: 0.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 85.30
| 1. Piotroski 6.0pt |
| 2. FCF Yield 11.13% |
| 3. FCF Margin 35.67% |
| 4. Debt/Equity 0.42 |
| 5. Debt/Ebitda -0.98 |
| 6. ROIC - WACC (= 30.04)% |
| 7. RoE 47.46% |
| 8. Rev. Trend 31.05% |
| 9. EPS Trend -8.94% |
What is the price of MC shares?
As of December 07, 2025, the stock is trading at USD 68.68 with a total of 1,131,156 shares traded.
Over the past week, the price has changed by +7.03%, over one month by +9.05%, over three months by -1.83% and over the past year by -4.98%.
Over the past week, the price has changed by +7.03%, over one month by +9.05%, over three months by -1.83% and over the past year by -4.98%.
Is MC a buy, sell or hold?
Moelis has received a consensus analysts rating of 2.63.
Therefor, it is recommend to hold MC.
- Strong Buy: 0
- Buy: 1
- Hold: 5
- Sell: 0
- Strong Sell: 2
What are the forecasts/targets for the MC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76.5 | 11.4% |
| Analysts Target Price | 76.5 | 11.4% |
| ValueRay Target Price | 79 | 15% |
MC Fundamental Data Overview December 02, 2025
Market Cap USD = 4.76b (4.76b USD * 1.0 USD.USD)
P/E Trailing = 21.3189
P/E Forward = 18.3824
P/S = 3.2435
P/B = 8.8751
P/EG = 1.97
Beta = 1.895
Revenue TTM = 1.47b USD
EBIT TTM = 277.4m USD
EBITDA TTM = 288.8m USD
Long Term Debt = 267.7m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 25.4m USD (from shortTermDebt, last fiscal year)
Debt = 223.2m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -281.6m USD (from netDebt column, last quarter)
Enterprise Value = 4.70b USD (4.76b + Debt 223.2m - CCE 281.6m)
Interest Coverage Ratio = -5.58 (Ebit TTM 277.4m / Interest Expense TTM -49.7m)
FCF Yield = 11.13% (FCF TTM 523.4m / Enterprise Value 4.70b)
FCF Margin = 35.67% (FCF TTM 523.4m / Revenue TTM 1.47b)
Net Margin = 15.98% (Net Income TTM 234.6m / Revenue TTM 1.47b)
Gross Margin = 32.89% ((Revenue TTM 1.47b - Cost of Revenue TTM 984.9m) / Revenue TTM)
Gross Margin QoQ = 28.43% (prev 28.61%)
Tobins Q-Ratio = 3.10 (Enterprise Value 4.70b / Total Assets 1.52b)
Interest Expense / Debt = 0.83% (Interest Expense 1.85m / Debt 223.2m)
Taxrate = 27.02% (22.2m / 82.3m)
NOPAT = 202.4m (EBIT 277.4m * (1 - 27.02%))
Current Ratio = 103.8 (out of range, set to none) (Total Current Assets 336.8m / Total Current Liabilities 3.24m)
Debt / Equity = 0.42 (Debt 223.2m / totalStockholderEquity, last quarter 535.0m)
Debt / EBITDA = -0.98 (Net Debt -281.6m / EBITDA 288.8m)
Debt / FCF = -0.54 (Net Debt -281.6m / FCF TTM 523.4m)
Total Stockholder Equity = 494.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.46% (Net Income 234.6m / Total Assets 1.52b)
RoE = 47.46% (Net Income TTM 234.6m / Total Stockholder Equity 494.3m)
RoCE = 36.40% (EBIT 277.4m / Capital Employed (Equity 494.3m + L.T.Debt 267.7m))
RoIC = 40.95% (NOPAT 202.4m / Invested Capital 494.3m)
WACC = 10.92% (E(4.76b)/V(4.98b) * Re(11.40%) + D(223.2m)/V(4.98b) * Rd(0.83%) * (1-Tc(0.27)))
Discount Rate = 11.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.12%
[DCF Debug] Terminal Value 70.74% ; FCFE base≈392.6m ; Y1≈470.0m ; Y5≈748.2m
Fair Price DCF = 102.2 (DCF Value 7.56b / Shares Outstanding 74.0m; 5y FCF grow 21.03% → 3.0% )
EPS Correlation: -8.94 | EPS CAGR: -17.83% | SUE: 0.64 | # QB: 0
Revenue Correlation: 31.05 | Revenue CAGR: -4.55% | SUE: -0.86 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.71 | Chg30d=-0.000 | Revisions Net=-3 | Analysts=9
EPS next Year (2026-12-31): EPS=3.32 | Chg30d=-0.057 | Revisions Net=+0 | Growth EPS=+24.7% | Growth Revenue=+17.1%
P/E Trailing = 21.3189
P/E Forward = 18.3824
P/S = 3.2435
P/B = 8.8751
P/EG = 1.97
Beta = 1.895
Revenue TTM = 1.47b USD
EBIT TTM = 277.4m USD
EBITDA TTM = 288.8m USD
Long Term Debt = 267.7m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 25.4m USD (from shortTermDebt, last fiscal year)
Debt = 223.2m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -281.6m USD (from netDebt column, last quarter)
Enterprise Value = 4.70b USD (4.76b + Debt 223.2m - CCE 281.6m)
Interest Coverage Ratio = -5.58 (Ebit TTM 277.4m / Interest Expense TTM -49.7m)
FCF Yield = 11.13% (FCF TTM 523.4m / Enterprise Value 4.70b)
FCF Margin = 35.67% (FCF TTM 523.4m / Revenue TTM 1.47b)
Net Margin = 15.98% (Net Income TTM 234.6m / Revenue TTM 1.47b)
Gross Margin = 32.89% ((Revenue TTM 1.47b - Cost of Revenue TTM 984.9m) / Revenue TTM)
Gross Margin QoQ = 28.43% (prev 28.61%)
Tobins Q-Ratio = 3.10 (Enterprise Value 4.70b / Total Assets 1.52b)
Interest Expense / Debt = 0.83% (Interest Expense 1.85m / Debt 223.2m)
Taxrate = 27.02% (22.2m / 82.3m)
NOPAT = 202.4m (EBIT 277.4m * (1 - 27.02%))
Current Ratio = 103.8 (out of range, set to none) (Total Current Assets 336.8m / Total Current Liabilities 3.24m)
Debt / Equity = 0.42 (Debt 223.2m / totalStockholderEquity, last quarter 535.0m)
Debt / EBITDA = -0.98 (Net Debt -281.6m / EBITDA 288.8m)
Debt / FCF = -0.54 (Net Debt -281.6m / FCF TTM 523.4m)
Total Stockholder Equity = 494.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.46% (Net Income 234.6m / Total Assets 1.52b)
RoE = 47.46% (Net Income TTM 234.6m / Total Stockholder Equity 494.3m)
RoCE = 36.40% (EBIT 277.4m / Capital Employed (Equity 494.3m + L.T.Debt 267.7m))
RoIC = 40.95% (NOPAT 202.4m / Invested Capital 494.3m)
WACC = 10.92% (E(4.76b)/V(4.98b) * Re(11.40%) + D(223.2m)/V(4.98b) * Rd(0.83%) * (1-Tc(0.27)))
Discount Rate = 11.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.12%
[DCF Debug] Terminal Value 70.74% ; FCFE base≈392.6m ; Y1≈470.0m ; Y5≈748.2m
Fair Price DCF = 102.2 (DCF Value 7.56b / Shares Outstanding 74.0m; 5y FCF grow 21.03% → 3.0% )
EPS Correlation: -8.94 | EPS CAGR: -17.83% | SUE: 0.64 | # QB: 0
Revenue Correlation: 31.05 | Revenue CAGR: -4.55% | SUE: -0.86 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.71 | Chg30d=-0.000 | Revisions Net=-3 | Analysts=9
EPS next Year (2026-12-31): EPS=3.32 | Chg30d=-0.057 | Revisions Net=+0 | Growth EPS=+24.7% | Growth Revenue=+17.1%
Additional Sources for MC Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle